SANTA MONICA, Calif., June 24, 2021 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) ("BioVie" or "Company"), a clinical-stage company developing innovative drug therapies for the treatment of liver ...
J Gastroenterol Hepatol. 2009;24(9):1494-1503. Transjugular Intrahepatic Portosystemic Shunting. Transjugular intrahepatic portosystemic shunting (TIPS) creates an iatrogenic intrahepatic shunt a ...
Static ultrasound guidance is used to select and mark the site of needle insertion immediately before the procedure takes place. Dynamic ultrasound guidance, in contrast, is used to directly visualize ...
Sequana Medical NV received premarket approval from the U.S. FDA for its Alfapump system to treat recurrent or refractory ascites due to liver cirrhosis. Data from the Poseidon pivotal study showed ...
Disparities in stage at presentation for disaggregated Asian American, Native Hawaiian, and Pacific Islander (AANHPI) groups with breast cancer. This is an ASCO Meeting Abstract from the 2024 ASCO ...
Ascites often develops as a complication of liver disease, causing fluid buildup in the abdominal cavity. Common treatments for ascites include reducing sodium intake, taking diuretics, and undergoing ...
Early initiation of diuretic therapy in patients with new onset cirrhotic ascites lowers 90-day mortality rate, according to a study in the American Journal of Gastroenterology. Researchers examined ...
This is the liver, and you can see the ascites here. This patient needs a paracentesis. First, check the liver and organs ...
AKI — Increase in serum creatinine ≥0.3 mg/dl within 48 hr or increase ≥1.5 times baseline level Increase in serum creatinine ≥0.3 mg/dl within 48 hr or increase ≥1.5 times baseline level, which is ...